(P507) Expanding the Horizons of Automated Insulin Delivery: a Pilot Study Bringing AID to Primary Care

Approximately 90% of diabetes care is delivered in primary care, including half of adult type 1 diabetes care. Yet technologies like automated insulin delivery systems have typically been managed by endocrinology much more so than primary care. As such systems become more complex in design but simpler in operation, their use must expand to all patients, including in primary care. AID systems are becoming more advanced, as technology always does, but with greater automation can come a decrease in the effort required of clinicians and patients in managing them. This poster describes a pilot study to evaluate the initiation and management of the iLet bionic pancreas AID system in both primary care and endocrinology settings, both in person and via telehealth to determine estimated effect size for sample size calculations for a larger scale, randomized controlled trial evaluating iLet in primary care.